Abstract
Protein prenylation, found in eukaryotes, is a posttranslational modification in which one or two isoprenoid groups are added to the C terminus of selected proteins using either a farnesyl group or a geranylgeranyl group. Prenylation facilitates protein localization mainly to the plasma membrane where the prenylated proteins, including small GTPases, mediate signal transduction pathways. Changes in the level of prenylated proteins may serve a critical function in a variety of diseases. Metabolic labeling using modified isoprenoid probes followed by enrichment and proteomic analysis allows the identities and levels of prenylated proteins to be investigated. In this protocol, we illustrate how the conditions for metabolic labeling are optimized to maximize probe incorporation in HeLa cells through a combination of in-gel fluorescence and densitometric analysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Marakasova ES, Akhmatova NK, Amaya M, Eisenhaber B, Eisenhaber F, van Hoek ML et al (2013) Prenylation: from bacteria to eukaryotes. Mol Biol 47:622–633
Zhang FL, Casey PJ (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 65:241–269.
Casey PJ, Solski PA, Der CJ, Buss JE (1989) p21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci U S A 86:8323–8327
Casey PJ, Thissen JA, Moomaw JF (1991) Enzymatic modification of proteins with a geranylgeranyl isoprenoid. Proc Natl Acad Sci U S A 88:8631–8635
Seabra MC, Goldstein JL, Südhof TC, Brown MS (1992) Rab geranylgeranyl transferase. A multisubunit enzyme that prenylates GTP-binding proteins terminating in Cys-X-Cys or Cys-Cys. J Biol Chem 267:14497–14503
Blanden MJ, Suazo KF, Hildebrandt ER, Hardgrove DS, Patel M, Saunders WP et al (2017) Efficient farnesylation of an extended C-terminal C(x)3X sequence motif expands the scope of the prenylated proteome. J Biol Chem 293:2770–2785
Boyartchuk VL, Ashby MN, Rine J (1997) Modulation of ras and a-factor function by carboxyl-terminal proteolysis. Science 80(275):1796–1800
Fujimura-Kamada K, Nouvet FJ, Michaelis S (1997) A novel membrane-associated metalloprotease, Ste24p, is required for the first step of NH2-terminal processing of the yeast a-factor precursor. J Cell Biol 136:271–285
Huyer G, Kistler A, Nouvet FJ, George CM, Boyle ML, Michaelis S (2006) Saccharomyces cerevisiae a-factor mutants reveal residues critical for processing, activity, and export. Eukaryot Cell 5:1560–1570
Schafer WR, Rine J (1992) Protein prenylation: genes, enzymes, targets, and functions. Annu Rev Genet 26:209–237
Liu Z, Meray RK, Grammatopoulos TN, Fredenburg RA, Cookson MR, Liu Y et al (2009) Membrane-associated farnesylated UCH-L1 promotes α-synuclein neurotoxicity and is a therapeutic target for Parkinson’s disease. Proc Natl Acad Sci U S A 106:4635–4640
Jeong A, Suazo KF, Wood WG, Distefano MD, Li L (2018) Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer’s disease. Crit Rev Biochem Mol Biol 53:279–310
Li H, Kuwajima T, Oakley D, Nikulina E, Hou J, Yang WS et al (2016) Protein Prenylation constitutes an endogenous brake on axonal growth. Cell Rep 16:545–558
Charron G, Li MMH, MacDonald MR, Hang HC (2013) Prenylome profiling reveals S-farnesylation is crucial for membrane targeting and antiviral activity of ZAP long-isoform. Proc Natl Acad Sci 110:11085–11090
Resh MD (2012) Targeting protein lipidation in disease. Trends Mol Med 18:206–214
Kale TA, Raab C, Yu N, Dean DC, Distefano MD (2001) A photoactivatable prenylated cysteine designed to study isoprenoid recognition. J Am Chem Soc 123:4373–4381
Vervacke JS, Funk AL, Wang Y-C, Strom M, Hrycyna CA, Distefano MD (2014) Diazirine-containing photoactivatable isoprenoid: synthesis and application in studies with isoprenylcysteine carboxyl methyltransferase. J Org Chem 79:1971–1978
Dozier JK, Khatwani SL, Wollack JW, Wang Y-C, Schmidt-Dannert C, Distefano MD (2014) Engineering protein farnesyltransferase for enzymatic protein labeling applications. Bioconjug Chem 25:1203–1212
Tate EW, Kalesh KA, Lanyon-hogg T, Storck EM, Thinon E (2015) Global profiling of protein lipidation using chemical proteomic technologies. Curr Opin Chem Biol 24:48–57
DeGraw AJ, Palsuledesai C, Ochocki JD, Dozier JK, Lenevich S, Rashidian M et al (2010) Evaluation of alkyne-modified isoprenoids as chemical reporters of protein prenylation. Chem Biol Drug Des 76:460–471
Suazo KF, Schaber C, Palsuledesai CC, Odom John AR, Distefano MD (2016) Global proteomic analysis of prenylated proteins in Plasmodium falciparum using an alkyne-modified isoprenoid analogue. Sci Rep 6:38615
Suazo KF, Hurben AK, Liu K, Xu F, Thao P, Sudheer C et al (2018) Metabolic labeling of prenylated proteins using alkyne-modified isoprenoid analogues. Curr Protoc Chem Biol 10(3):e46
Palsuledesai CC, Ochocki JD, Kuhns MM, Wang YC, Warmka JK, Chernick DS et al (2016) Metabolic labeling with an alkyne-modified isoprenoid analog facilitates imaging and quantification of the prenylome in cells. ACS Chem Biol 11:2820–2828
Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425–430
Hosokawa A, Wollack JW, Zhang Z, Chen L, Barany G, Distefano MD (2007) Evaluation of an alkyne-containing analogue of farnesyl diphosphate as a dual substrate for protein-prenyltransferases. Int J Pept Res Ther 13:345–354
Acknowledgments
This work was supported in part by the National Institutes of Health (RF1AG056976 and GM084152) and by the National Science Foundation grant (CHE-1308655).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Ahmadi, M., Suazo, K.F., Distefano, M.D. (2019). Optimization of Metabolic Labeling with Alkyne-Containing Isoprenoid Probes. In: Linder, M. (eds) Protein Lipidation. Methods in Molecular Biology, vol 2009. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9532-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9532-5_3
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9531-8
Online ISBN: 978-1-4939-9532-5
eBook Packages: Springer Protocols